Thomas Weimbs, PhD & Jessianna Saville, RDN Autosomal dominant polycystic kidney disease (PKD) is a common genetic disorder with limited drug therapy options. PKD progresses relentlessly leading to dramatic and often painful kidney and liver enlargement. Approximately 60% of affected...
Oxalates and PKD? If you have polycystic kidney disease (PKD), you may be curious about whether or not you should avoid foods with oxalates. In this article, we review the relationship between kidney disease and oxalates including: *What oxalates are...
Fighting PKD at the Dinner Table: Researchers examine the role of low-carb/low-sugar diets in warding off polycystic kidney disease By Sonia Fernandez The team of UC Santa Barbara biochemist Thomas Weimbs published the results of a clinical study that gives the first...
What Now? Navigating the challenges of Polycystic Kidney Disease (PKD) can often feel like a solitary endeavor, especially when your ideas about self-care aren’t shared by your healthcare provider.Having hope, as a PKD patient, often hinges on feeling empowered –...
Beta-hydroxybutyrate (BHB) is a term you might have come across when delving into the research around Polycystic Kidney Disease (PKD) management. But what exactly is BHB, and how can it play a role in slowing PKD progression? Let’s explore. Understanding...
